What Is the Downside of Nerve Ablation?

Nerve ablation reliably interrupts pain signals, but its core downside is that the relief is temporary: the treated nerves regenerate over months, pain returns, and the procedure often needs to be repeated. Beyond recurrence, nerve ablation carries a list of risks that vary by body region and technique, from post-procedure pain flares and muscle weakening to rare but serious complications like complex regional pain syndrome. The procedure also faces a credibility challenge, with some research suggesting that a meaningful share of its benefit comes from the placebo effect rather than the nerve destruction itself.

Pain Recurrence and the Repeat-Procedure Cycle

The most universal downside of nerve ablation is that it works by design as a reversible injury. The procedure destroys the nerve’s inner layers while leaving its outer scaffolding intact, which allows the nerve fiber to slowly regrow along the same path. This is intentional: a permanent nerve injury would risk lasting motor or sensory loss. But the trade-off is that when the nerve regenerates, pain signals resume.

How quickly pain returns depends on the technique and the nerve being treated. One study comparing radiofrequency ablation (RFA) with alcohol ablation for thoracolumbar facet joint pain found that the median effective period for RFA was about 10.7 months, meaning half the patients had recurring pain before the one-year mark.¹ For many people, this means scheduling repeat procedures every year or two indefinitely. Each repeat session carries the same risks as the first, and the cumulative burden of multiple procedures, including time off work, sedation exposure, and the emotional toll of returning pain, is a real cost that does not always get discussed upfront.

The underlying biology makes this essentially unavoidable with current techniques. Nerve ablation interrupts axonal continuity and triggers degeneration of the nerve fibers downstream from the lesion, but the surrounding connective tissue framework stays intact, acting as a guide rail for regrowth.² You cannot make the ablation more destructive to extend relief without also making it more likely to cause permanent damage. That tension between durability and safety is baked into the procedure.

Post-Procedure Pain Flares and Neuritis

It sounds counterintuitive, but a procedure designed to reduce pain can temporarily make it worse. Many patients experience a post-procedure flare in the days or weeks following ablation. This happens because the ablation itself creates a fresh injury to nerve tissue, producing local inflammation and irritation. The flare usually settles within a few weeks, but for some people it can be severe enough to feel like the procedure backfired.

A related concern is neuritis, an inflammatory response along the treated nerve. Thermal radiofrequency ablation in particular carries this risk because of the heat involved. The nerve and surrounding tissue become inflamed, producing burning or shooting pain along the nerve’s path that can last for weeks. While neuritis is generally self-limiting, it can be distressing when you were expecting immediate relief. Some clinicians prescribe a short course of anti-inflammatory medication or oral steroids to manage the flare, but not all patients are warned about it in advance.

Neuroma Formation

A neuroma is a tangled ball of nerve tissue that can form when a severed nerve tries to regenerate but gets disorganized along the way. In theory, nerve ablation should carry some risk of neuroma formation, since it disrupts the nerve. In practice, reported cases are extremely rare. A comprehensive literature review found only a single case report describing neuroma formation after lumbar facet medial branch radiofrequency ablation.³ The rarity may be explained by the fact that ablation preserves the nerve’s outer structural layers, giving regenerating fibers a clear path to follow rather than leaving them to sprout chaotically. Still, the possibility exists, and a neuroma at a treated site could produce pain that is worse and more difficult to treat than the original problem.

Collateral Damage to Nearby Structures

Nerve ablation does not happen in a vacuum. The energy used, whether heat from radiofrequency, extreme cold from cryoablation, or chemical agents, radiates outward from the probe tip. When the target nerve sits near skin, bowel, blood vessels, or other nerves, those structures can be injured. Thermal ablation in musculoskeletal procedures carries a recognized risk of damage to adjacent skin, intestinal tissue, and neural structures.⁴ Practitioners use techniques like injecting fluid to insulate vulnerable tissue, but the risk cannot be eliminated entirely.

Motor nerve injury is a specific version of this problem. Most pain-focused ablations target sensory nerves, but sensory and motor fibers often run close together or share the same nerve trunk. In cryoablation procedures near musculoskeletal tumors, about a third of cases showed some decrease in motor-nerve signals during the procedure. In most of those, the change was temporary, but a small number of patients had persistent signal drops, and half of those developed actual motor deficits afterward.⁵ The good news is that even when motor nerves are inadvertently ablated, regeneration tends to happen. A study of patients who had cryoablation of mixed or motor nerves found that all patients eventually recovered muscle activation, with nerve regrowth proceeding at roughly 1.5 millimeters per day.⁶ But “eventually” can mean months of weakness depending on how far the damaged nerve needs to regrow to reach the muscle.

Lumbar Spine Ablation and Muscle Weakening

One of the most common uses of nerve ablation is for low back pain, where radiofrequency is applied to the medial branch nerves of the lumbar facet joints. These nerves carry pain signals from the spine’s small joints, but they also supply the multifidus, a deep muscle that plays a key role in stabilizing the lower back. Destroying the nerve to eliminate pain may also partially denervate this stabilizing muscle.

A systematic review of the evidence found that studies using electromyography confirmed denervation of the multifidus after lumbar radiofrequency ablation, and ultrasound measurements showed a meaningful reduction in the muscle’s stiffness.⁷ Imaging studies gave mixed results: two out of four studies found decreases in muscle size or increases in fat infiltration, while the others showed no change or even an increase. The review’s authors were cautious, noting that the available evidence was modest in quality and quantity. But the concern is real: if the multifidus weakens, spinal stability could worsen over time, potentially trading short-term pain relief for longer-term mechanical problems.⁸ This is an area where the science is still catching up to the practice, and patients considering repeated lumbar ablation procedures should be aware that cumulative effects on spinal muscles remain an open question.

Phrenic Nerve Injury in Cardiac Ablation

Nerve ablation is also widely used in the heart to treat atrial fibrillation, where the goal is to destroy cardiac tissue creating abnormal electrical signals. In this context, the phrenic nerve, which controls the diaphragm, runs dangerously close to the ablation targets. Phrenic nerve injury causes diaphragm paralysis on the affected side, leading to shortness of breath and reduced exercise tolerance.⁹

The risk varies substantially by technique. Cryoballoon ablation, which uses freezing energy, carries a notably higher phrenic nerve injury rate than radiofrequency or the newer pulsed field ablation. A meta-analysis found that cryoballoon ablation had roughly ten times the odds of phrenic nerve injury compared to radiofrequency at twelve-month follow-up. Most of these injuries resolved on their own, with only one case of permanent injury reported across the included studies.¹⁰ Pulsed field ablation, a newer approach designed to be more selective for cardiac tissue, showed the lowest phrenic injury rate at about 0.23%, compared to roughly 0.6% for radiofrequency and nearly 2.7% for cryoballoon.

Complex Regional Pain Syndrome

Perhaps the most alarming potential complication is developing a pain condition worse than the one you started with. Complex regional pain syndrome (CRPS) is a chronic condition characterized by severe, burning pain that is disproportionate to any ongoing injury, often accompanied by swelling, skin color changes, and temperature changes in the affected limb. At least one documented case exists of CRPS developing after radiofrequency ablation of the genicular nerves for chronic knee pain. The patient developed escalating pain along with visible changes in the knee about ten weeks after the ablation, and ultimately required a different intervention, dorsal root ganglion stimulation, to manage the condition.¹¹

CRPS after nerve ablation is rare, but it illustrates a broader principle: destroying a nerve is itself a form of nerve injury, and the nervous system does not always respond to injury in predictable ways. Some nervous systems seem primed to overreact, producing amplified pain signals that spread beyond the original site. There is no reliable way to predict who is at risk for this kind of paradoxical response before the procedure.

The Placebo Problem

A less obvious downside of nerve ablation is that a meaningful portion of the benefit may not come from the nerve destruction at all. Randomized trials comparing real radiofrequency ablation to sham procedures, where patients go through the entire process but no energy is actually delivered, have produced surprisingly mixed results. Many of the larger sham-controlled trials found no statistically significant difference between real and fake ablation, and patients who received the sham treatment often reported substantial pain improvement.¹²

This does not mean nerve ablation is useless. The placebo effect is itself a real neurobiological phenomenon, and if a patient’s pain improves, the mechanism matters less than the outcome from a quality-of-life standpoint. But it does matter when you are weighing risks. If a significant chunk of the benefit would have occurred with a sham procedure, the risk-benefit calculus shifts: you are accepting all of the potential complications described above while receiving only a fraction of the benefit from the actual nerve destruction. This is particularly relevant for patients with high levels of depression or anxiety, who appear less likely to benefit from the placebo component and therefore may see less overall improvement from the procedure.

When Ablation Cannot Address the Real Source of Pain

Nerve ablation treats the signal, not the cause. This works well when the pain is generated at a specific peripheral site, like an inflamed facet joint sending signals through a well-defined nerve. But chronic pain often involves changes in the spinal cord and brain itself, a process where the central nervous system becomes increasingly sensitized and begins amplifying pain signals independently of what is happening at the original site. When this has occurred, ablating the peripheral nerve may provide little or no relief because the central nervous system continues generating pain on its own. Glial cells in the spinal cord and brain release inflammatory molecules that sustain this amplified state, and no amount of peripheral nerve destruction will quiet that process.

This is one reason some patients get disappointing results from ablation even when the diagnostic nerve block beforehand suggested it should work. The block temporarily floods the area with local anesthetic, silencing all signals temporarily. But the ablation only destroys the target nerve, and if the pain is being maintained centrally, the temporary silence during the block does not predict lasting relief from ablation.

Renal Denervation and Non-Response

Nerve ablation is not limited to pain treatment. Renal denervation, which ablates sympathetic nerves along the kidney arteries to lower blood pressure, has emerged as an option for resistant hypertension. The procedure’s main downside here is a substantial non-response rate: somewhere between 8% and 37% of patients see little or no meaningful blood pressure reduction afterward.¹³ In one study, over half the patients were classified as non-responders.¹⁴

Procedural complications in renal denervation trials have generally been uncommon, mostly involving access-site vascular problems like pseudoaneurysms and the occasional renal artery dissection during catheter deployment. In the large SYMPLICITY HTN-3 trial, only one of 364 patients had an access-site complication.¹⁵ But given that a large fraction of patients may not benefit at all, those procedural risks, however small, are borne without corresponding reward for non-responders. And unlike pain ablation, where a diagnostic block can at least attempt to predict who will respond, there is no reliable pre-procedure test to identify who will benefit from renal denervation.

How Different Ablation Methods Compare on Risk

The specific risks of nerve ablation shift depending on the energy source used. Radiofrequency ablation uses heat to create a small, controlled lesion. Its risks lean toward post-procedure neuritis and the possibility of thermal damage to nearby structures. Cryoablation uses extreme cold, which tends to preserve the nerve’s outer architecture better and may allow cleaner regeneration, but it creates a larger zone of tissue injury. In cardiac applications, cryoballoon ablation carried roughly 1.9 times the overall complication odds of radiofrequency, though the difference was not statistically significant. The standout risk was phrenic nerve injury, where cryoballoon carried ten times the odds compared to radiofrequency.¹⁶

Chemical ablation using agents like alcohol can produce longer-lasting denervation. The facet joint study mentioned earlier found that alcohol ablation maintained pain relief for a median of 24 months, compared to about 10.7 months for radiofrequency on the same nerves.¹ The trade-off is that more destructive techniques are less predictable in their spread and more likely to damage surrounding tissue. Choosing a technique is always a balancing act between how long the relief lasts and how much collateral risk you accept.

The Cost and Burden of Ongoing Treatment

Because nerve ablation is inherently a repeating procedure for most patients, its economic footprint extends well beyond the initial session. Modeling studies have found that for specific applications, like ablation of the basivertebral nerve for vertebrogenic chronic low back pain, the procedure can be cost-effective relative to ongoing standard care over a five-year horizon.¹⁷ But cost-effectiveness analyses compare against the alternative of continued conservative treatment, not against a cure. The patient is still cycling through clinical visits, imaging, and repeat procedures, each carrying its own out-of-pocket costs, recovery time, and the psychological weight of knowing that the relief has an expiration date.

For patients without robust insurance coverage, the cumulative cost of repeated ablations can be substantial. And when you factor in the possibility that some of the benefit is placebo-driven, or that the patient might fall into the non-responder category, the financial risk becomes harder to justify without careful patient selection and honest pre-procedure counseling about what the evidence actually shows.